These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia. Nawata J, Toyoda Y, Nisihira H, Honda K, Kigasawa H, Nagao T. Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392 [Abstract] [Full Text] [Related]
5. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. Kurzrock R, Talpaz M, Gutterman JU. Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572 [Abstract] [Full Text] [Related]
7. Hematologic response in patients with aplastic anemia after long-term administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. Yonekura S, Kawada H, Watanabe S, Masumoto A, Ogawa Y, Fukuda R, Nishihira H, Matsuyama S, Katoh S, Mouri H, Motomura S, Shionoya S, Hotta T. Clin Ther; 1997 Jul; 19(6):1394-407. PubMed ID: 9444448 [Abstract] [Full Text] [Related]
8. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin]. Hanamura A, Ichikawa A, Utsumi M, Hotta T. Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170 [Abstract] [Full Text] [Related]
9. Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia. Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Matsumoto S, Sakamaki S, Niitsu Y, Hinoda Y. Am J Hematol; 1995 Jan; 48(1):29-33. PubMed ID: 7530405 [Abstract] [Full Text] [Related]
12. Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group. Thompson JA, Gilliland DG, Prchal JT, Bennett JM, Larholt K, Nelson RA, Rose EH, Dugan MH. Blood; 2000 Feb 15; 95(4):1175-9. PubMed ID: 10666187 [Abstract] [Full Text] [Related]
14. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF]. Higashino K, Kito K, Hodohara K, Fujiyama Y, Banba T, Hosoda S. Rinsho Ketsueki; 1992 Sep 15; 33(9):1237-41. PubMed ID: 1279235 [Abstract] [Full Text] [Related]
15. Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Hellström-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P. Br J Haematol; 1997 Nov 15; 99(2):344-51. PubMed ID: 9375752 [Abstract] [Full Text] [Related]
17. Treatment of anemia in low risk myelodysplastic syndromes with granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin. Economopoulos T, Mellou S, Papageorgiou E, Pappa V, Kokkinou V, Stathopoulou E, Pappa M, Raptis S. Leukemia; 1999 Jul 15; 13(7):1009-12. PubMed ID: 10400415 [Abstract] [Full Text] [Related]
18. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group. Remacha AF, Arrizabalaga B, Villegas A, Manteiga R, Calvo T, Julià A, Fernández Fuertes I, González FA, Font L, Juncà J, del Arco A, Malcorra JJ, Equiza EP, de Mendiguren BP, Romero M. Haematologica; 1999 Dec 15; 84(12):1058-64. PubMed ID: 10586205 [Abstract] [Full Text] [Related]